NAOV — NanoVibronix Share Price
0.000.00%
Last trade - 00:00- $2.12m
- -$1.17m
- $2.28m
- 27
- 63
- 20
- 30
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.53 | ||
| Price to Tang. Book | 0.53 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.93 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -81.42% | ||
| Return on Equity | -102.78% | ||
| Operating Margin | -150.5% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.53 | 0.62 | 1.7 | 0.75 | 2.28 | n/a | n/a | 48.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
NanoVibronix, Inc. is a medical device company. The Company is focused on developing noninvasive biological response-activating devices utilizing its low-intensity surface acoustic wave (SAW) technology. Its primary products consist of UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use, which markets in the United States under Food and Drug Administration (FDA) policy of enforcement discretion during the COVID-19 pandemic and is undergoing clinical testing. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD and PainShield Plus.
Directors
- Christopher Fashek NEC (71)
- Brian Murphy CEO (64)
- Stephen Brown CFO (65)
- Harold Jacob OTH (67)
- Aurora Cassirer IND
- Michael Ferguson IND (50)
- Martin Goldstein IND (53)
- Thomas Mika IND (69)
- Maria Schroeder IND
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- October 20th, 2003
- Public Since
- April 24th, 2015
- No. of Shareholders
- 131
- No. of Employees
- 10
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 2,784,354
- Address
- 525 Executive Blvd, ELMSFORD, 10523
- Web
- https://nanovibronix.com/
- Phone
- +1 9142333004
- Auditors
- Marcum LLP
Upcoming Events for NAOV
Nanovibronix Inc Annual Shareholders Meeting
Q2 2024 Nanovibronix Inc Earnings Release
Similar to NAOV
Accelerate Diagnostics
NASDAQ Capital Market
Acutus Medical
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the NanoVibronix share price?
As of Today at 19:14 UTC, shares in NanoVibronix are trading at $0.76. This share price information is delayed by 15 minutes.
How has the NanoVibronix share price performed this year?
Shares in NanoVibronix last closed at $0.76 and the price had moved by -75.72% over the past 365 days. In terms of relative price strength the NanoVibronix share price has underperformed the S&P500 Index by -80.39% over the past year.
What are the analyst and broker recommendations for NanoVibronix?
The overall consensus recommendation for NanoVibronix is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the NanoVibronix dividend yield?
NanoVibronix does not currently pay a dividend.
Does NanoVibronix pay a dividend?
NanoVibronix does not currently pay a dividend.
When does NanoVibronix next pay dividends?
NanoVibronix does not currently pay a dividend.
How do I buy NanoVibronix shares?
To buy shares in NanoVibronix you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of NanoVibronix?
As of the previous close price of $0.76, shares in NanoVibronix had a market capitalisation of $2.12m.
Where are NanoVibronix shares listed?
Here are the trading details for NanoVibronix:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: NAOV
What kind of share is NanoVibronix?
Based on an overall assessment of its quality, value and momentum NanoVibronix is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a NanoVibronix share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the NanoVibronix share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NanoVibronix. Over the past six months, its share price has underperformed the S&P500 Index by -43.59%.
As of the last closing price of $0.76, shares in NanoVibronix were trading -52.55% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the NanoVibronix PE Ratio?
The NanoVibronix PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.76.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of NanoVibronix?
NanoVibronix's management team is headed by:
- Christopher Fashek - NEC
- Brian Murphy - CEO
- Stephen Brown - CFO
- Harold Jacob - OTH
- Aurora Cassirer - IND
- Michael Ferguson - IND
- Martin Goldstein - IND
- Thomas Mika - IND
- Maria Schroeder - IND